Global Glycomics/Glycobiology Market
WiseGuyRerports.com Presents “Global Glycomics/Glycobiology Market Size, Status and Forecast 2018-2025” New Document to its Studies Database. The Report Contain 94 Pages With Detailed Analysis.
This report focuses on the global Glycomics/Glycobiology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glycomics/Glycobiology development in United States, Europe and China.
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics “is the systematic study of all glycan structures of a given cell type or organism” and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, “glyco-“, and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
The classification of Glycomics/Glycobiology includes instruments, enzymes, reagents and kits and the proportion of instruments in 2017 is about 34%, and the proportion is in decreasing trend from 2013 to 2017.
Glycomics/Glycobiology is widely used for drug discovery & development, diagnostics and other feild. The most proportion of Glycomics/Glycobiology is used for drug discovery & development, and the proportion in 2017 is 52.4%.
North America is the largest consumption place, with a consumption market share nearly 37% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 29%.
In 2017, the global Glycomics/Glycobiology market size was 730 million US$ and it is expected to reach 1730 million US$ by the end of 2025, with a CAGR of 11.5% during 2018-2025.
The key players covered in this study
Takara Bio, Inc.
New England Biolabs
Market segment by Type, the product can be split into
Market segment by Application, split into
Drug Discovery & Development
Market segment by Regions/Countries, this report covers
Central & South America
Table of Contents -Major Key Points
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Glycomics/Glycobiology Market Size Growth Rate by Type (2013-2025)
1.5 Market by Application
1.5.1 Global Glycomics/Glycobiology Market Share by Application (2013-2025)
1.5.2 Drug Discovery & Development
1.6 Study Objectives
1.7 Years Considered
12 International Players Profiles
12.1 ThermoFisher Scientific
12.1.1 ThermoFisher Scientific Company Details
12.1.2 Company Description and Business Overview
12.1.3 Glycomics/Glycobiology Introduction
12.1.4 ThermoFisher Scientific Revenue in Glycomics/Glycobiology Business (2013-2018)
12.1.5 ThermoFisher Scientific Recent Development
12.2.1 Danaher Company Details
12.2.2 Company Description and Business Overview
12.2.3 Glycomics/Glycobiology Introduction
12.2.4 Danaher Revenue in Glycomics/Glycobiology Business (2013-2018)
12.2.5 Danaher Recent Development
12.3 Shimadzu Corporation
12.3.1 Shimadzu Corporation Company Details
12.3.2 Company Description and Business Overview
12.3.3 Glycomics/Glycobiology Introduction
12.3.4 Shimadzu Corporation Revenue in Glycomics/Glycobiology Business (2013-2018)
12.3.5 Shimadzu Corporation Recent Development
12.4.1 ProZyme Company Details
12.4.2 Company Description and Business Overview
12.4.3 Glycomics/Glycobiology Introduction
12.4.4 ProZyme Revenue in Glycomics/Glycobiology Business (2013-2018)
12.4.5 ProZyme Recent Development
12.5 Takara Bio, Inc.
12.5.1 Takara Bio, Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Glycomics/Glycobiology Introduction
12.5.4 Takara Bio, Inc. Revenue in Glycomics/Glycobiology Business (2013-2018)
12.5.5 Takara Bio, Inc. Recent Development
12.6 Agilent Technologies
12.6.1 Agilent Technologies Company Details
12.6.2 Company Description and Business Overview
12.6.3 Glycomics/Glycobiology Introduction
12.6.4 Agilent Technologies Revenue in Glycomics/Glycobiology Business (2013-2018)
12.6.5 Agilent Technologies Recent Development
12.7.1 Bruker Company Details
12.7.2 Company Description and Business Overview
12.7.3 Glycomics/Glycobiology Introduction
12.7.4 Bruker Revenue in Glycomics/Glycobiology Business (2013-2018)
12.7.5 Bruker Recent Development
12.8.1 Promega Company Details
12.8.2 Company Description and Business Overview
12.8.3 Glycomics/Glycobiology Introduction
12.8.4 Promega Revenue in Glycomics/Glycobiology Business (2013-2018)
12.8.5 Promega Recent Development
Tags: glycomics glycobiology market, Glycomics/ Glycobiology, Glycomics/ Glycobiology market trend, Glycomics/Glycobiology Market SegmentationSee Campaign: https://www.wiseguyreports.com/reports/3455049-global-glycomics-glycobiology-market-size-status-and-
NORAH TRENT Partner Relations & Marketing Manager firstname.lastname@example.org www.wiseguyreports.com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)
, Research Newswire, Press Release, Private Equity, Venture Capital, Seed funding, North America, South America, United States, Latin America, United Kingdom, Europe, Africa, Asia, Middle East, English